We are a clinical research organisation with extensive experience in early-phase clinical trials, specialising in first-in-human (FIH), pharmacokinetic (PK), pharmacodynamic (PD), proof-of-concept (PoC) and regulatory studies. Our CPU and clinical trial management and support teams provide comprehensive, end-to-end services, for a diverse range of trials—from simple to complex—for investigational small molecules, biologics and other innovative therapies.
learn more
We are committed to supporting your bioanalysis project every step of the way, from discovery through phase 4. We share your goal to provide high-quality drugs to patients as quickly as possible. Our scientific expertise ranges from assay development, assay transfer and optimisation, through assay validation (according to current international guidelines) to routine analysis to support pharmacokinetics (PK), immunogenicity, pharmacodynamics (PD) and biomarker testing. Furthermore, our GLP-accredited facilities and advanced technologies help deliver precise results for small and large molecules to get your drug to market faster.
learn more
We specialise in biomarker analysis, providing tailored solutions to support drug development and patient care. Biomarkers are critical for early disease detection, developing personalised treatment plans and evaluating therapeutic efficacy. Our team of experts delivers meaningful data through advanced platforms, including LC-MS/MS, ligand binding assays and flow cytometry. By considering the context-of-use (CoU), we develop strategies designed to meet each project’s unique needs, driving impactful decisions. Our clinical laboratory delivers high-quality data to support safety and pharmacodynamic biomarkers.
learn more
Nuvisan provides end-to-end clinical trial supply services, including packaging, labelling and logistics. Our expertise ensures timely delivery of trial materials worldwide, maintaining compliance with regulatory standards.
learn more
Contact Us
Search